Save
Developing a novel stem cell and gene therapy system based on resveratrol-induced HSP70 promoter-regulated VEGFA expression
ISTH Academy, KowitYu Chong, 264712
The mammalian target of rapamycin controls platelet integrin activation, aggregation, and ischemic stroke
ISTH Academy, Robert Campbell, 264728
The role of NMDA receptors in platelet specific hemostasis
ISTH Academy, Lili Donner, 264746
Effect of monomeric myeloperoxidase on platelet function
ISTH Academy, Irina Gorudko, 264763
Recombinant ADAMTS13 (TAK-755/SHP655) can override the inhibitory effect of free hemoglobin on von Willebrand factor (VWF) multimer cleavage in vitro
ISTH Academy, Werner Hoellriegl, 264781
Acquired thrombotic thrombocytopenic purpura occurring in advanced age: impact of a delayed onset on disease expression
ISTH Academy, Andrea Artoni, 264798
Sex-specific Differences in the Clinical Presentation, Surgical Complications, and Course of Chronic Thromboembolic Pulmonary Hypertension (CTEPH): Insights from the European CTEPH Registry
ISTH Academy, Stefano Barco, 264815
Features of thrombosis of the vena cava on a series of 1045 vein thrombosis
ISTH Academy, Mohamed Habib Houman, 264832
Cerebral venous thrombosis: a study about 1045 cases
ISTH Academy, Mohamed Habib Houman, 264848
Direct Oral Anticoagulant Laboratory Assay Assessment at a Large Academic Medical Center
ISTH Academy, Sharonlin Bhardwaj, 264865
Changes in the thrombocytic link of the hemostasis system in pregnant women with preeclampsia
ISTH Academy, Bakhodir Kurbanov, 264888
New Classification of Protein S Deficiency - Role as a Co-factor of Tissue Factor Pathway Inhibitor
ISTH Academy, Herm Brinkman, 274996
Natural Changes in Natural Anticoagulants
ISTH Academy, Vera Ignjatovic, 274997
Laboratory Diagnosis and Phenotypic Characterization of Antithrombin Deficiency and Antithrombin Deficiency Registry
ISTH Academy, Zsuzsanna Bereczky, 274998
Interferance with Classical Methods
ISTH Academy, Cecilia Guillermo, 274999
New Method to Test Protein S
ISTH Academy, Eriko Morishita, 275000
Use of Protein C Concentrates
ISTH Academy, Leonardo Brandao, 275001
Discussion for Future Projects
ISTH Academy, Jun Teruya, 275002
Introduction
ISTH Academy, Kathleen Freson, 275003
Tier1 Genes and Gold Variants for Bleeding, Thrombotic and Platelet Disorders
ISTH Academy, Karyn Megy, 275004
The ClinGen Working Group for Thrombosis and Hemostasis
ISTH Academy, Jorge Di Paola, 275005
Diagnostics of Inherited Thrombocytopenia: A Clinical Perspective
ISTH Academy, Patrizia Noris, 275006
Ethical Considerations When Applying Gene Panel Tests for Platelet Disorders
ISTH Academy, Andreas Greinacher, 275007
French Genomics Initiatives for Rare and Common Venous Thrombosis
ISTH Academy, Pierre Emmanuel Morange, 275008
Whole Genome Sequencing Study for Platelet Function
ISTH Academy, Andrew Johnson, 275009
Complex Genetics for Platelet Traits
ISTH Academy, Willem Ouwehand, 275010
Genetic Control of Platelet Gene Expression
ISTH Academy, Leonard Edelstein, 275011
Update and Proposal of Standardization Projects
ISTH Academy, Matthew Locke, 275012
SSC Project Update: Validation of the t-AUCi Parameter Using ROTEM to Assess Fibrinolytic Resistance in Septic Patients
ISTH Academy, Ecaterina Scarlatescu, 275013
Trauma Induced Coagulopathy: The Need for Nomenclature Standardization
ISTH Academy, Satoshi Gando, 275014
Finding Consensus in Defining Trauma Induced Coagulopathy: Part 1
ISTH Academy, Hunter Moore, 275015
Finding Consensus in Defining Trauma Induced Coagulopathy: Part 2
ISTH Academy, Beverley Hunt, 275016
Bridging the Gap to Find Consensus on Trauma Induced Coagulopathy Nomenclature: Updates from the Tranexamic Acid/Trauma Symposia
ISTH Academy, Dominik Drexler, 275017
Open Discussion: SSC Consensus Statement on Trauma Induced Coagulopathy
ISTH Academy, Paul Kim, 275018
Welcome: Outline of the Women’s SSC and Overview of Activities
ISTH Academy, Maha Othman, 275019
Challenges in the Management of Von Willebrand Disease in Pregnancy: Results from an International Survey
ISTH Academy, Michelle Lavin, 275020
Hemophilia Carrier Nomenclature: Proposed Terminology to Improve Communication
ISTH Academy, Robert Sidonio, 275021
Setting Standards for Appropriate and Necessary Care for Young Women with Heavy Menstrual Bleeding and Bleeding Disorders: An International Panel Survey
ISTH Academy, Ayesha Zia, 275022
The MAPP Registry: Thrombolysis and Invasive Treatments for Massive Pregnancy-Related Pulmonary
ISTH Academy, Marc Blondon, 275023
The Role of Tissue Plasminogen Activator in Reproductive and Depressive Disorders: The Hibernation Model
ISTH Academy, Silvia Hoirisch-Clapauch, 275024
A New Algorithm Based on Thrombin Generation to Assess Hormone-Related Prothrombotic Changes
ISTH Academy, Jonathan Douxfils, 275025
International Registry on Disseminated Intravascular Coagulation in Pregnancy
ISTH Academy, Offet Erez, 275026
Concluding Remarks
ISTH Academy, Maha Othman, 275027
Disseminated Intravascular Coagulation in Non-Human Primate Models of Sepsis
ISTH Academy, Florea Lupu, 275028
What Vitamin C Is Purported to Do? 
ISTH Academy, Donald Brophy, 275029
Clot Wave Form Analysis for Disseminated Intravascular Coagulation
ISTH Academy, Hideo Wada, 275030
Recombinant Thrombomodulin for Sepsis-Induced Coagulopathy
ISTH Academy, Kazuma Yamakawa, 275031
Constructing the Japanese Guidelines for Sepsis Management 2020
ISTH Academy, Yutaka Umemura, 275033
Assessment of Fibrinolysis in Sepsis
ISTH Academy, Ecaterina Scarlatescu, 275034
Welcome
ISTH Academy, John-Bjarne Hansen, 275035
Standardized Assessment of Bleeding Risk in Venous Thromboembolism Patients Initiating Anticoagulant Treatment
ISTH Academy, Geert-Jan Geersing, 275039
Biomarkers for and Prediction of Venous Thromboembolism After Stroke
ISTH Academy, Vania Morelli, 275040
Prediction of Death in Acute Pulmonary Embolism
ISTH Academy, Stefano Barco, 275041
von Willebrand Factor Induces Human Vascular Smooth Muscle Cells Proliferatio through Low Density Lipoprotein-related Receptor Protein 4 and αvβ3 Integrin
ISTH Academy, Cecile Denis, 273746
Prophylactic Inhibition of Factor XI Contact Activation Enhances Deep Vein Thrombosis Resolution in an in vivo Model of Inferior Vena Caval Constriction
ISTH Academy, Khanh Nguyen, 273766
Fibrinolysis in Patients with Chemotherapy Induced Thrombocytopenia and the Effect of Platelet Transfusion
ISTH Academy, Floor Heubel-Moenen, 273768
Rare Bleeding Disorders in the Netherlands - Update
ISTH Academy, Joline Saes, 273795
Impact of miR-204 on Human Platelet-like Structures
ISTH Academy, Alix Garcia, 273803
Age at First Disease Manifestation in Relation to Residual ADAMTS13 Activity in Patients with Congenital Thrombotic Thrombocytopenic Purpura
ISTH Academy, Erika Tarasco, 273808
Emicizumab Treatment is Efficacious and Well Tolerated Long Term in Persons with Haemophilia A (PwHA) with or without FVIII Inhibitors: Pooled Data from Four HAVEN Studies
ISTH Academy, Michael Callaghan, 273812
High-throughput Sorting of Platelet Aggregates by Intelligent Image-activated Cell Sorting
ISTH Academy, Atsushi Yasumoto, 273818
Successful Treatment of Pregnant Patients with Congenital Thrombotic Thrombocytopenic Purpura Using Prophylactic Fresh Frozen Plasma Infusion
ISTH Academy, Kazuya Sakai, 273819
Efficacy of Recombinant ADAMTS13 (TAK-755/SHP655) in a Humanized Mouse Model for Sickle Cell Disease
ISTH Academy, Werner Hoellriegl, 273829
A Single-arm, Multicentre, Open-Label, Phase III Clinical Trial to Evaluate the Safety and Tolerability of Prophylactic Emicizumab in Persons with Haemophilia A (PwHA) with FVIII Inhibitors (STASEY): Interim Analysis Results
ISTH Academy, Victor Jiménez-Yuste, 273830
Protease Activated Receptor 4 Activation Requires a Coordinated Rearrangement of Extracellular Loop 3 and Thr153 in the Ligand Binding Site Formed by TM3 and TM7
ISTH Academy, Xu Han, 273836
Identification of a Possible Allosteric Disulfide in the αIIb Subunit of Platelet αIIbβ3 Integrin
ISTH Academy, Aster Pijning, 273841
Correcting Bleeding Disorders Using Blood Clotting Factors Produced in vivo by Shielded Engineered Allogeneic Cells
ISTH Academy, David Peritt, 273856
Identification of Amino Acids that are Crucial for FXIII-A Subunit Interactions and Stability
ISTH Academy, Bojun Li, 273857
Suppression of Human Macrophage NLRP3 Inflammasome Activity by Activated Protein C or by PAR1-derived and PAR3-derived Peptides
ISTH Academy, Laura Healy, 273866
Acute Submassive Pulmonary Embolism is Not Associated with an Increased Rate of Chronic Thromboembolic Pulmonary Hypertension
ISTH Academy, Hannah Stevens, 273870
DNAse-dependent but NETs-independent Pathway of Thrombus Formation in vivo
ISTH Academy, Estelle Carminita, 273880
Surgical Experience from Four Phase III Studies (HAVEN 1-4) of Emicizumab in Persons with Haemophilia A (PwHA) with or without FVIII Inhibitors
ISTH Academy, Elena Santagostino, 273889
External Validation of Radiological Signs of Chronic Thromboembolic Pulmonary Hypertension on Computed Tomography Pulmonary Angiography at the Time of Suspected Pulmonary Embolism
ISTH Academy, Duliëtte Boon, 273891
Diagnosis of Pulmonary Embolism Using D-Dimer Thresholds Selected According to Clinical Pre-Test Probability
ISTH Academy, Kerstin de Wit, 273910
Genetic Landscape in Korean Adult Patients with Atypical Hemolytic Uremic Syndrome
ISTH Academy, Jae Won Yun, 273923
Platelet Actomyosin Response to Flow or Substrate Stiffness-induced Biomechanical Forces
ISTH Academy, David Bark, 273934
Platelet Lamellipodia Formation Is Not Required for Thrombus Formation and Stability
ISTH Academy, Yvonne Schurr, 273948
Mapping the Interaction with Vwf and Fxii and Its Potential as a New Anti-coagulant Target
ISTH Academy, Patricia Henne, 273950
FXa Inhibitors Target Tumor-associated Macrophage FXa-PAR2 Signaling
ISTH Academy, Claudine Graf, 273973
Development of a Formulation for Oral Delivery of FVIII via a Robotic Pill
ISTH Academy, Gerald Schrenk, 273977
VWFA1 Interacts with Scavenger Receptor LRP1 via Lysine 1408
ISTH Academy, Alain Chion, 273980
Machine-learning Algorithms Can Improve upon Current Methods of Risk-stratification of Patients Presenting with Suspected Deep Vein Thrombosis
ISTH Academy, John Willan, 273984
Possible Indicators for High Shear Thrombosis: An Enlarged Cell-free Layer and High Shear Rate
ISTH Academy, Britt Johanna Maria van Rooij, 273996
Platelet Deficiency of ERp5 Is Compensated for by Increased Levels of ERp57 and PDI
ISTH Academy, Angelina Lay, 274027
Evaluation of Different Therapeutic Strategies to Manage the Rare Coagulation Defect Induced by Thrombomodulin c.1611C>Ap.Cys537Stop Mutation
ISTH Academy, Gael Morrow, 274037
Investigation of Recanalization and Cerebral Perfusion with Adjunctive Thrombolytic Therapies in the iCAT Mouse Model of Ischemic Stroke
ISTH Academy, Jessica Maclean, 274043
Acquired Haemophilia A: 25 Years of Experience in The Netherlands
ISTH Academy, Sarah Schep, 274045
Emicizumab for the Treatment of Acquired Hemophilia A
ISTH Academy, Paul Knoebl, 274077
Slc44a2 Deficient Mice Exhibit Less Severity of Thrombosis in a Stenosis Model of DVT
ISTH Academy, Chrissta Maracle, 274078
Mepacrine Uptake Can Be Used in the Diagnosis of Platelet Dense Granule Deficiency
ISTH Academy, Rolf Urbanus, 274080
A Test of the GPIbα β-switch Hypothesis for Platelet-type von Willebrand Disease
ISTH Academy, Matthew Auton, 274089
Potential Multifactorial Mechanisms for Hormone-induced Venous Thromboembolism
ISTH Academy, Jordan Shavit, 274097
Platelet but Not Plasma Protein S Limitsthrombus Growthin Large Veinsbut Not in Large Arteriesby Controlling Coagulation in situ
ISTH Academy, Sara Calzavarini, 274113
Knockout of von Willebrand Factor in Zebrafish by CRISPR/Cas9 Mutagenesis
ISTH Academy, Pudur Jagadeeswaran, 274121
Predicting Venous Thromboembolism Risk after Immobilization of the Lower-limb for Trauma: Update and Validation of a Clinical Risk Assessment Model, the TRiP(Cast) Score
ISTH Academy, Delphine Douillet, 274126
The Prevalence of Giant Platelets in Children without Platelet Disorders on Screening Blood Counts
ISTH Academy, Michele Lambert, 274135
CLOTSref: A Mobile Application for Standardized Reference Ranges in Developmental Haemostasis
ISTH Academy, Paul Thuan Tieu, 274137
Using a Mathematical Model of Platelet Aggregation in an Extravascular Injury to Investigate Modifiers of Primary Hemostasis
ISTH Academy, Keith Neeves, 274140
Identification of a Possible Allosteric Disulfide in the αIIb Subunit of Platelet αIIbβ3 Integrin
ISTH Academy, Aster Pijning, 275136
von Willebrand Factor Induces Human Vascular Smooth Muscle Cells Proliferatio through Low Density Lipoprotein-related Receptor Protein 4 and αvβ3 Integrin
ISTH Academy, Cecile Denis, 275138

Anonymous User Privacy Preferences

Strictly Necessary Cookies (Always Active)

MULTILEARNING platforms and tools hereinafter referred as “MLG SOFTWARE” are provided to you as pure educational platforms/services requiring cookies to operate. In the case of the MLG SOFTWARE, cookies are essential for the Platform to function properly for the provision of education. If these cookies are disabled, a large subset of the functionality provided by the Platform will either be unavailable or cease to work as expected. The MLG SOFTWARE do not capture non-essential activities such as menu items and listings you click on or pages viewed.


Performance Cookies

Performance cookies are used to analyse how visitors use a website in order to provide a better user experience.



Google Analytics is used for user behavior tracking/reporting. Google Analytics works in parallel and independently from MLG’s features. Google Analytics relies on cookies and these cookies can be used by Google to track users across different platforms/services.


Save Settings